Stock vs Stock Comparison

Gen Digital Inc. vs Axcelis Technologies, Inc.

GEN wins the Tale of the Tape 7–2.

GEN$26.50
ACLS

🏆 Tale of the Tape

72
GENACLS
16.3%Profitability (Net Margin)14.3%
16.4xValuation (P/E)24.1x
10.0%Efficiency (ROIC)9.8%
8/9Health (Piotroski F)5/9
1.0Safety (Altman Z)7.3
3.5%Growth (Rev YoY)-17.6%
-0.96Risk (Sharpe 1Y)
5.83xBalance Sheet (D/E)0.32x
6.70%FCF Yield3.95%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricGENACLS
Market Cap$15.5B$2.8B
P/E Ratio16.4x24.1x
Forward P/E7.8x20.3x
P/B5.91x2.72x
Dividend Yield1.94%
Beta1.091.76

Quantitative Metrics

MetricGENACLS
DCF Fair Value$77.17$24.44
DCF Upside+308.1%
Piotroski F8/95/9
Altman Z1.017.31
Beneish M-2.80-2.07
FCF Yield6.70%3.95%
Net Debt/EBITDA3.4x-0.6x
ROIC10.0%9.8%
WACC8.6%15.4%
ROIC – WACC1.5pp-5.7pp
Gross Margin80.3%44.9%
Net Margin16.3%14.3%
Rev Growth YoY3.5%-17.6%
Sharpe (1Y)-0.96
Max Drawdown 3Y
FCF Payout Ratio26%

GEN Price

Loading chart...

ACLS Price

Loading chart...

ETF Exposure

GEN found in:

HACK4.38%
XSW0.82%
VBR0.24%
RSP0.17%
DGRW0.14%
VB0.13%
VGT0.10%
XLK0.09%
QUS0.09%
ONEO0.07%
GWX0.05%
SPYV0.05%
SCHV0.04%
VYM0.04%
IWD0.03%
IVV0.03%
SPLG0.02%
ITOT0.02%
SPY0.02%
SPTM0.02%
SCHX0.02%
ESGV0.02%
VOO0.02%
SCHB0.02%
URTH0.02%
ACWI0.01%
IWF0.00%
SPDW0.00%
VONG0.00%

ACLS found in:

SLY0.59%
SLYG0.36%
SPSM0.28%
SLYV0.20%
VTWO0.13%
VBR0.10%
VGT0.07%
SPTM0.01%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

GEN vs ACLS: Head-to-Head Analysis

Gen Digital Inc. (GEN) and Axcelis Technologies, Inc. (ACLS) represent two companies in the Technology sector. In our quantitative Tale of the Tape scoring, GEN leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, GEN generates a return on invested capital (ROIC) of 10.0% compared to ACLS's 9.8%. This suggests GEN is more effective at deploying capital to generate shareholder returns.

GEN appears in 29 ETFs tracked by SecuritiesDB, while ACLS appears in 8 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, GEN or ACLS?

Our quantitative analysis compares GEN and ACLS across nine fundamental dimensions. GEN wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are GEN and ACLS correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.